Zhejiang Orient Gene Biotech Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 6,381.982 million compared to CNY 828.150 million a year ago. Operating income was CNY 3,995.355 million compared to CNY 605.768 million a year ago. Net income was CNY 3,394.249 million compared to CNY 523.946 million a year ago. Basic earnings per share from continuing operations was CNY 28.29 compared to CNY 4.37 a year ago.